Who is sponsoring NCT03429725?

NCT03429725 is sponsored by Yale-NUS College.

What drugs are being tested in NCT03429725?

Interventions in NCT03429725: Online prime (statements writing), Online prime (circling), Online prime (Sumarian Warrior), Online prime (all).

What condition does NCT03429725 study?

NCT03429725 studies Individual Difference.

Is NCT03429725 still recruiting?

NCT03429725 is currently completed. Last updated 13 February 2018.

Last reviewed 2018-02-13 · How we verify

NCT03429725

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Increasing Individualism and Collectivism

Completed NA Last updated 13 February 2018

What this trial tests

NA trial testing Online prime (statements writing) in Individual Difference in 495 participants. Completed in 23 October 2017.

Timeline

17 September 2017

Primary endpoint
23 October 2017

23 October 2017

Quick facts

Lead sponsor	Yale-NUS College
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	health services research
Enrollment	495
Start date	17 September 2017
Primary completion	23 October 2017
Estimated completion	23 October 2017
Sites	1 location across Singapore

Drugs / interventions tested

Online prime (statements writing)
Online prime (circling)
Online prime (Sumarian Warrior)
Online prime (all)

Conditions studied

Individual Difference — all drugs for Individual Difference →

Sponsor

Yale-NUS College

Who can join

21 and older, any sex, with Individual Difference. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

An online survey is conducted on MTurk populations from India and USA. Participants were assigned either a condition with primes of individualism or one with primes of collectivism, before responding to a scale on culture and indicating details of their demographics.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Yale-NUS College trials

Trials by the same sponsor.

NCT06440785 — Taylor Swift and Mental Health Outcomes · recruiting
NCT06440798 — Mental Health Content and Mental Health Outcomes · recruiting
NCT04967846 — Social Media Effects on Mental Health · completed
NCT04918849 — WhatsApp in India During the COVID-19 Pandemic · unknown
NCT04448704 — Understanding the Mental Health of Migrant Workers During the COVID-19 Outbreak · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03429725 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yale-NUS College
Last refreshed: 13 February 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03429725.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing